v3.26.1
Consolidated Income Statement - CAD ($)
$ in Millions
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Profit or loss [abstract]    
Revenue $ 4,914.0 $ 4,707.9
Cost of sales 3,523.2 3,407.8
Gross profit 1,390.8 1,300.1
Research and development expenses 144.0 123.2
Selling, general and administrative expenses 624.3 565.4
Other (gains) and losses 8.5 (13.3)
Share of after-tax profit of equity accounted investees (82.7) (88.3)
Restructuring, integration and acquisition costs 84.4 56.5
Gain on remeasurement of previously held equity interest 0.0 (72.6)
Operating income 612.3 729.2
Finance expense – net 212.1 215.5
Earnings before income taxes 400.2 513.7
Income tax expense 77.5 98.7
Net income 322.7 415.0
Attributable to:    
Equity holders of the Company 313.1 405.3
Non-controlling interests $ 9.6 $ 9.7
Earnings per share attributable to equity holders of the Company    
Basic (in dollars per share) $ 0.98 $ 1.27
Diluted (in dollars per share) $ 0.97 $ 1.27